Member Info for upupandawaybby

Well my second top up this afternoon since mega Monday.
The only thing that I’m focusing on is gradually selling everything to keep increasing my holdings here
Since mega Monday I hate weekends and dreading the bank hol

Back to 220 this share is unreal they keep trying to knock it down and she just keeps going

up to 550k now

Ghia, seeing as we are grammar policing i thought i'd point out it's it's too not to ;)

At the moment I will be happy with £2-£5B, however if the COPD results are "more than we could have ever hoped for" like the hospitalised results I'll be increasing my target to £10B+

Yes double my top end pre results target as COPD market dwarfs COVID

Thanks for your response really appreciated.

With Gold taking a massive dip and other AIM gold/silver companies dropping some tanking, it's great to see us holding firm

Good luck to you Right on and keep up the good work

Yep morning Doji has 3 completed and Harami cross has 1 with tech indicators showing STRONG buy

Big bullish reversal look son the cards, poss back to resistance of 224?

Yes I read that on Share talk

Not posted for a while, this share is like Carol Voderman.
You would but you wouldn't admit it, bought myself another 60k shares yesterday, Just don't tell anyone ;)

I will continue to top this share up and up, excluding gold/mining I only hold CTEA, GDR (Gemma Collins) and SNG (Charlize Theron) hoping CTEA goes from a Carol to a Charlize this month or maybe even a Margot Robbie!

So when factoring in the Hardman research excludes the value of gold, copper and other metals in Empire (confirmed resources) plus Navarre plus the White Knob Mining Group, and the Cobalt in Bighorn and Redcastle, are we looking more towards $2.5B with only 63 million shares in issue give us roughly 40 dollars a share or £30?
Is this correct or have I missed something?

"game changers and products that meet unmet needs"

SNG to a T

https://www.fiercebiotech.com/special-report/venrock-associates

(Thanks Robortsmith)

Huge success in this industry, New York ii & will have excellent contacts.

Firms like this no exactly what they are doing and I think they are nearly as confident as I am ;)

They have 1-Venrock Healthcare Capital Partners,
2 VCHP
3 VHCP
crafty beggers

Bong Koh and Nimish Shah have 3.4
VCHP Management have 3.4
Venrock Healthcare Capital Partners III have 3.2

Total 10%

Venrock have already crossed threshold we have had an RNS, this must be another one?

I just look at what’s currently available as a treatment for copd, asthma basically viral infections Seasonal flu, new strains of future covid etc
By 2022 COPD will be a 20B market a year on its own
I expect SNG001 will prove far more effective than what’s currently available and will be the go to drug
Is there any competition on the horizon? Yes
but I can only think of 1 in Canada also neb using ifn b
Is there opportunity realistically for SNG to take 10% market share based on what alternative treatments are available? Absolutely that’s 2B just on copd a year
Example of viral treatment drug, symbicort for AZN generates 700m a year.
The top 3 new revenue drugs this year are all forecast to earn 1.5 billion a year Within the next 3 years and the top one is for migraines not a life saving drug
Factor in covid and shelf life, stockpiling
I’m beginning to think I’ve low balled the buyout actually
Last year biggest buyout was 11B no covid maybe it will be 15B this year when we got bought who knows

I’ve been here since beginning of March and have posted multiple times Sharing research I’ve found myself.
I did all the links, the common sense and the facts all the way through clearly stating numerous occasions “if it goes to 10p it doesn’t matter all that matters is I keep building my holdings until those results come out”
I have posted even more, sharing articles and my own thoughts etc on social media investing groups than I have on here and have gotten a rather large following
Now I prefer more light hearted posts, I’m confident in what I’ve read up back in Feb, confident sng will deliver and even more confident that the share price will be between £13.50 - £33.50

I’ve said it before and I’ll say it again, biggest interferon b manufacturer in the world Biogen 45B mcap has gone up 10% in the last 30 minutes since open that’s 4 billion.
Have they got a large order coming in?
Which company needs shed loads of interferon b?
I can think of 1 for sure
They did start tests the day after our results came out to so these are still top of my list

We raised £14M in cash in April we don’t need to raise again

Stuck at 220 or above to buy for 40 minutes now